Career history of David M. Spencer
Former positions of David M. Spencer
| Companies | Position | Start | End |
|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2004-07-13 | 2019-02-28 |
| Founder | 2004-07-13 | 2019-02-28 | |
| KIROMIC BIOPHARMA, INC. | Director/Board Member | 2019-09-30 | - |
| Chief Tech/Sci/R&D Officer | 2019-09-30 | - | |
| Baylor College of Medicine | Corporate Officer/Principal | - | - |
Training of David M. Spencer
| Massachusetts Institute of Technology | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| KIROMIC BIOPHARMA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
- Stock Market
- Insiders
- David M. Spencer
- Experience
